UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.033

Sortiert nach

Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

European journal of heart failure, 2019-06, Vol.21 (6), p.715-731

2019

Link zum Volltext

Verfügbarkeit prüfen

Toward Standardization of Mesenchymal Stromal Cell‐Derived Extracellular Vesicles for Therapeutic Use: A Call for Action

Proteomics (Weinheim), 2019-01, Vol.19 (1-2), p.e1800397-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of low‐dose colchicine in acute and chronic coronary syndromes: A systematic review and meta‐analysis

European journal of clinical investigation, 2021-04, Vol.51 (4), p.e13464-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Head-to-Head Comparison of 2 Myocardial Fibrosis Biomarkers for Long-Term Heart Failure Risk Stratification

Journal of the American College of Cardiology, 2014-01, Vol.63 (2), p.158-166

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical translation of mesenchymal stromal cell extracellular vesicles: Considerations on scientific rationale and production requisites

Journal of cellular and molecular medicine, 2022-02, Vol.26 (3), p.937-939

2022

Link zum Volltext

Verfügbarkeit prüfen

New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology‐voltage‐P‐wave duration)

Annals of noninvasive electrocardiology, 2019-11, Vol.24 (6), p.e12669-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Iron status measurement in routine heart failure assessment: a call for action

European journal of heart failure, 2018-01, Vol.20 (1), p.123-124

2018

Link zum Volltext

Verfügbarkeit prüfen

Decellularized pericardial extracellular matrix: The preferred porous scaffold for regenerative medicine

Xenotransplantation (Københaven), 2020-01, Vol.27 (1), p.e12580-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence

Scientific reports, 2021-06, Vol.11 (1), p.12025-12025, Article 12025

2021

Link zum Volltext

Verfügbarkeit prüfen

Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis

Scientific reports, 2022-03, Vol.12 (1), p.4691-4691, Article 4691

2022

Link zum Volltext

Verfügbarkeit prüfen

Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure

European journal of heart failure, 2012-01, Vol.14 (1), p.32-38

2012

Link zum Volltext

Verfügbarkeit prüfen

Head-to-head comparison of two engineered cardiac grafts for myocardial repair: From scaffold characterization to pre-clinical testing

Scientific reports, 2018-04, Vol.8 (1), p.6708-13, Article 6708

2018

Link zum Volltext

Verfügbarkeit prüfen

Reply to the letter regarding the article ‘Head‐to‐head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines’

European journal of heart failure, 2024-02, Vol.26 (2), p.525-526

2024

Link zum Volltext

Verfügbarkeit prüfen

The CONCERT‐HF trial: a sweet and sour symphony

European journal of heart failure, 2021-04, Vol.23 (4), p.675-676

Bayes‐Genis, Antoni

2021

Link zum Volltext

Verfügbarkeit prüfen

Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018

Scientific reports, 2021-01, Vol.11 (1), p.732-732, Article 732

2021

Link zum Volltext

Verfügbarkeit prüfen

Unlocking the potential of natriuretic peptide testing in primary care: A roadmap for early heart failure diagnosis

European journal of heart failure, 2023-08, Vol.25 (8), p.1181-1184

2023

Link zum Volltext

Verfügbarkeit prüfen

Interatrial block and atrial arrhythmias in centenarians: Prevalence, associations, and clinical implications

Heart rhythm, 2016-03, Vol.13 (3), p.645-651

2016

Link zum Volltext

Verfügbarkeit prüfen

Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic

Journal of the American Heart Association, 2017-10, Vol.6 (10), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Reply to ‘The frail patient and the frailing heart’

European journal of heart failure, 2023-03, Vol.25 (3), p.441-442

2023

Link zum Volltext

Verfügbarkeit prüfen

Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillation

Scientific reports, 2022-05, Vol.12 (1), p.7910-7910, Article 7910

2022

Link zum Volltext

Verfügbarkeit prüfen

The Heart Failure Association endorses the 25in25 initiative

European journal of heart failure, 2023-05, Vol.25 (5), p.602-603

2023

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers of inflammation in heart failure: from risk prediction to possible treatment targets

European journal of heart failure, 2023-02, Vol.25 (2), p.161-162

2023

Link zum Volltext

Verfügbarkeit prüfen

The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations

Scientific reports, 2021-03, Vol.11 (1), p.5940-5940, Article 5940

2021

Link zum Volltext

Verfügbarkeit prüfen

The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction

Scientific reports, 2021-11, Vol.11 (1), p.22155-22155, Article 22155

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.033

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(888)
Mit Volltextzugriff
(999)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(678)
Life Sciences & Biomedicine
(649)
Cardiovascular System & Cardiology
(510)
Cardiac & Cardiovascular Systems
(508)
Humans
(490)
Heart Failure
(276)
Female
(266)
Male
(258)
Aged
(204)
Prognosis
(177)
Middle Aged
(163)
Cardiovascular
(161)
Mortality
(109)
Cardiology
(96)
Biomarkers
(92)
Heart
(92)
Prospective Studies
(86)
Myocardial Infarction
(75)
Risk Factors
(75)
Aged, 80 And Over
(72)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

Toward Standardization of Mesenchymal Stromal Cell‐Derived Extracellular Vesicles for Therapeutic Use: A Call for Action

Effect of low‐dose colchicine in acute and chronic coronary syndromes: A systematic review and meta‐analysis

Head-to-Head Comparison of 2 Myocardial Fibrosis Biomarkers for Long-Term Heart Failure Risk Stratification

Clinical translation of mesenchymal stromal cell extracellular vesicles: Considerations on scientific rationale and production requisites

New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology‐voltage‐P‐wave duration)

Iron status measurement in routine heart failure assessment: a call for action

Decellularized pericardial extracellular matrix: The preferred porous scaffold for regenerative medicine

Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence

Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis

Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure

Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC-HFA EORP Heart Failure Long-Term Registry

Head-to-head comparison of two engineered cardiac grafts for myocardial repair: From scaffold characterization to pre-clinical testing

Reply to the letter regarding the article ‘Head‐to‐head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines’

The CONCERT‐HF trial: a sweet and sour symphony

Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018

Unlocking the potential of natriuretic peptide testing in primary care: A roadmap for early heart failure diagnosis

Interatrial block and atrial arrhythmias in centenarians: Prevalence, associations, and clinical implications

Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic

Reply to ‘The frail patient and the frailing heart’

Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillation

The Heart Failure Association endorses the 25in25 initiative

Biomarkers of inflammation in heart failure: from risk prediction to possible treatment targets

The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations

The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction

Suchergebnisse filtern